Mesa Laboratories (NASDAQ:MLAB) Issues Earnings Results, Beats Estimates By $0.66 EPS

Mesa Laboratories (NASDAQ:MLAB) posted its quarterly earnings results on Tuesday. The medical instruments supplier reported $2.07 EPS for the quarter, beating the consensus estimate of $1.41 by $0.66, Zacks reports. Mesa Laboratories had a negative net margin of 107.56% and a positive return on equity of 28.52%.

Mesa Laboratories Stock Up 9.6 %

MLAB opened at $146.74 on Tuesday. The company has a fifty day moving average of $132.85 and a two-hundred day moving average of $125.36. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.51 and a current ratio of 0.70. Mesa Laboratories has a fifty-two week low of $83.68 and a fifty-two week high of $149.50. The stock has a market capitalization of $796.80 million, a price-to-earnings ratio of -3.19 and a beta of 0.83.

Mesa Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, February 28th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, February 28th. This represents a $0.64 annualized dividend and a yield of 0.44%. Mesa Laboratories’s dividend payout ratio is presently -1.40%.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday, November 13th.

About Mesa Laboratories

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.